NDC 72162-1625-01 - Spironolactone and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-1625
- Requested NDC
- 72162-1625-01
- Package NDCs from labels
- 72162-1625-0, 72162-1625-1, 72162-1625-3, 72162-1625-4, 72162-1625-5, 72162-1625-6, 72162-1625-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-03-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Spironolactone and Hydrochlorothiazide - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-03-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-1625-0 | Spironolactone and Hydrochlorothiazide | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 107 | |
| 72162-1625-1 | Spironolactone and Hydrochlorothiazide | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 107 | |
| 72162-1625-3 | Spironolactone and Hydrochlorothiazide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 107 | |
| 72162-1625-4 | Spironolactone and Hydrochlorothiazide | 1000 in 1 BOTTLE, PLASTIC | TABLET | 1000 | 107 | |
| 72162-1625-5 | Spironolactone and Hydrochlorothiazide | 500 in 1 BOTTLE, PLASTIC | TABLET | 500 | 107 | |
| 72162-1625-6 | Spironolactone and Hydrochlorothiazide | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 107 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-1625 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLET [BRYANT RANCH PREPACK] | 103 | Current NDC, 6 package rows | 20240920_b3228678-7992-4148-b4ab-aa0d8b1b8570.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-1625-0 | EA - Each | 72162-1625 | 80e4d34b-73b6-43b6-b701-b03b0bfdba2d | 1 | 2024-10-04 |
| 72162-1625-1 | EA - Each | 72162-1625 | f1befe5c-8e07-47f8-85ed-e1beab4b3be1 | 1 | 2024-01-04 |
| 72162-1625-3 | EA - Each | 72162-1625 | 23581e8f-7626-4465-96cf-fc626ba87093 | 1 | 2024-01-04 |
| 72162-1625-4 | EA - Each | 72162-1625 | 85002e63-3d8d-4018-8a71-957594fac2dd | 1 | 2025-08-11 |
| 72162-1625-5 | EA - Each | 72162-1625 | 32249ef1-7f3d-4710-999f-8fd434d1cc35 | 1 | 2024-03-12 |
| 72162-1625-6 | EA - Each | 72162-1625 | bd5d6bc5-d262-42a8-916f-d7d7d91f9763 | 1 | 2024-01-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Spironolactone | SPIRONOLACTONE | PD-Rx Pharmaceuticals, Inc. | c0efa529-2870-4260-b604-2f30e2cbb87b | 2026-08-07 | Warnings, Adverse reactions | 27O7W4T232 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Shield Pharmaceuticals Corp | 0be906d8-3db5-4218-bbdf-f1d126007990 | 2026-08-07 | Warnings | F05Q2T2JA0 |
| bisoprolol fumarate and hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Unichem Pharmaceuticals (USA), Inc. | b9ee689a-ea12-435d-b01c-70d45891e62f | 2026-08-06 | Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 31a3d1cb-0f52-4818-965d-7584374bb23e | 2026-08-06 | Warnings, Adverse reactions | 0J48LPH2TH |
| Stool Softener Extra Strength | DOCUSATE SODIUM | P & L Development, LLC | 4e97dd60-96e3-4b51-b614-c62480af1919 | 2026-08-06 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | P & L Development, LLC | 098d2377-0019-45fe-b995-700b1b1241c4 | 2026-08-05 | Warnings | F05Q2T2JA0 |
| Docusate Sodium softgels 50mg (Dye Free) | DOCUSATE SODIUM | CVS Pharmacy | 273ea95f-3c9c-98e8-e063-6294a90a2135 | 2026-08-05 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | P & L Development, LLC | cbb0edf4-1fa7-42f5-a6f7-027e3961b50a | 2026-08-05 | Warnings | F05Q2T2JA0 |
| ROROBELL WAWA Whitening Tooth | SILICA, HYDROGEN PEROXIDE, TOCOPHERYL ACETATE | ROROBELL | 58336a0d-49dd-ef13-e063-6394a90a38c1 | 2026-08-04 | Warnings | ETJ7Z6XBU4 |
| Silicea 6X | SILICON DIOXIDE | Hyland's Inc. | db4be3c1-aa7e-24a2-e053-2a95a90a0c66 | 2026-08-04 | Warnings | ETJ7Z6XBU4 |
| Colace | DOCUSATE SODIUM | Atlantis Consumer Healthcare, Inc. | 7793fced-e8ee-44e2-b212-dd2a59a5f462 | 2026-08-04 | Warnings | F05Q2T2JA0 |
| Dual Action Senna Stool Softener | DOCUSATE SODIUM 50 MG, SENNOSIDES 8.6 MG | Shield Pharmaceuticals Corp | a04435df-aace-497f-a3a8-d8e8489db661 | 2026-08-03 | Warnings | F05Q2T2JA0 |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Proficient Rx LP | 43a4d6dd-bcca-412c-b051-ed470208ddb6 | 2026-08-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Bisoprolol Fumarate and Hydrochlorothiazide | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | Viona Pharmaceuticals Inc | 57505d73-f2a8-430b-8703-a0a6bb733c7d | 2026-07-31 | Warnings, Adverse reactions | 0J48LPH2TH |
| SPIRONOLACTONE | SPIRONOLACTONE | Sun Pharmaceutical Industries, Inc. | c23b6b9b-aec3-48a8-a518-76e4097f6479 | 2026-07-31 | Warnings, Adverse reactions | 27O7W4T232 |
| Smogstat | ECHINACEA (ANGUSTIFOLIA), HYPERICUM PERFORATUM, HYDRASTIS CANADENSIS, SYMPHYTUM OFFICINALE, ARSENICUM ALBUM, CARBO VEGETABILIS, CAUSTICUM, KALI CARBONICUM, NATRUM SULPHURICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA | Energique, Inc. | 59f63e2b-24fa-43a0-8334-02e6729c6ac1 | 2026-07-31 | Warnings | ETJ7Z6XBU4 |
| Muscle Ice | PHYTOLACCA DECANDRA, BELLIS PERENNIS, LEDUM PALUSTRE, RUTA GRAVEOLENS, SYMPHYTUM OFFICINALE, MAGNESIA PHOSPHORICA, SILICEA, MENTHOL (CRYSTALS) | Peaceful Mountain, Inc. | 03b6e2a9-f335-4ae2-9011-80bd019afb72 | 2026-07-30 | Warnings | ETJ7Z6XBU4 |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 167f49f0-2d39-49a2-9f9e-1359a7c7ba3d | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| SPIRONOLACTONE | SPIRONOLACTONE | Redpharm Drug | 57d1c333-c229-54aa-e063-6394a90a84ce | 2026-07-30 | Warnings, Adverse reactions | 27O7W4T232 |
| Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE | Hyland's Inc. | dd0a7ed2-d112-4b96-e053-2995a90ac6b6 | 2026-07-30 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.